Skip to main content

Metacrine, Inc.

MTCRDelisted Mar 3, 2023
Industry
Pharmaceutical Preparations
SEC CIK
0001634379

Metacrine, Inc. was delisted on Mar 3, 2023; its insiders filed their last Form 4 on Mar 24, 2023; 29 institutions reported holding it in 13F filings for Q4 2022, worth $7.29M in total; no superinvestor held it.

Q1 2023 vs. Q4 2022

How the institutions holding Metacrine, Inc. changed between Q4 2022 and Q1 2023.

All holders in Q1 2023All holders in Q4 2022

13F holders of MTCR: Q4 2022 compared with Q1 2023
MeasureQ4 2022Q1 2023Change
Holders295−24
Shares16.3M9.29M−6.99M (−42.9%)
Value$7.29M$5.30M−$1.99M (−27.3%)

New holders (1)

Institutions that held Metacrine, Inc. at the end of Q1 2023 but not at the end of Q4 2022.

Institutions new to MTCR in Q1 2023
InstitutionSharesValue% of portfolio
JBF Capital, Inc.1,945,270$1.11M0.25%

Sold out (25)

Institutions that held Metacrine, Inc. at the end of Q4 2022 and filed for Q1 2023 without it.